Chemoimmunotherapy: reengineering tumor immunity Gang ChenLeisha A. Emens Review 07 February 2013 Pages: 203 - 216
Proposed mechanism of off-target toxicity for antibody–drug conjugates driven by mannose receptor uptake Boris GorovitsCorinna Krinos-Fiorotti Perspectives 08 December 2012 Pages: 217 - 223
Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer Stephanie K. BuntAshley M. MohrMichael A. Hollingsworth Original Article 05 August 2012 Pages: 225 - 236
The antitumor effect of the Toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant Yu-Kun HuangZhi ZhengFu Qiu Original article 07 August 2012 Pages: 237 - 244
T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment Saskia J. A. M. SantegoetsAnita G. M. StamTanja D. de Gruijl Original article 10 August 2012 Pages: 245 - 256
Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells Ilseyar AkhmetzyanovaGennadiy ZelinskyyUlf Dittmer Original Article Open access 14 August 2012 Pages: 257 - 271
CD40 pathway activation reveals dual function for macrophages in human endometrial cancer cell survival and invasion Geneviève DumasMathieu DufresneCarlos Reyes-Moreno Original article 18 August 2012 Pages: 273 - 283
Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation Willemijn HoboTatiana I. NovobrantsevaHarry Dolstra Original article 19 August 2012 Pages: 285 - 297
Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies Austin DuffyFei ZhaoTim F. Greten Original Article 22 August 2012 Pages: 299 - 307
Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation Katja HattarRajkumar SavaiUlrich Grandel Original article Open access 26 August 2012 Pages: 309 - 320
Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy Ashley J. KnightsJitka FucikovaJonathan Cebon Original article 26 August 2012 Pages: 321 - 335
DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer Xavier TekpliNina E. LandvikShanbeh Zienolddiny Original article 26 August 2012 Pages: 337 - 345
CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells Masayasu NaitoUrsula HainzGordon J. Freeman Original article Open access 25 August 2012 Pages: 347 - 357
MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR Carolina M. SotoJennifer D. StoneDavid M. Kranz Original article 25 August 2012 Pages: 359 - 369
The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen Joel F. AldrichMichael H. ShearerRobert K. Bright Original Article 25 August 2012 Pages: 371 - 382
Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo Miki TonguNanae HarashimaMamoru Harada Original Article 25 August 2012 Pages: 383 - 391
Identification of a novel HLA-A2-restricted mutated Survivin epitope and induction of specific anti-HCC CTLs that could effectively cross-recognize wild-type Survivin antigen Han ShenHong-Wei ShaoShu-Lin Huang Original Article 29 August 2012 Pages: 393 - 403